Trial intelligence / Profile preview

Sustained-release methylphenidate for ADHD in adult male offenders with amphetamine dependence

2006-002249-35Phase 2Completed

Sponsor
Beroendecentrum Stockholm
Start
Jun 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) and amphetamine dependence comparing Concerta plus psychosocial relapse prevention with Placebo plus psychosocial relapse prevention (2 arms). Started Jun 2006; status: completed.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)amphetamine dependence

Beyond the preview

Go deeper on 2006-002249-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-002249-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call